PROPORTIONS OF PATIENTS ACHIEVING A MINIMAL DISEASE ACTIVITY STATE UPON TREATMENT WITH TILDRAKIZUMAB IN A PSORIATIC ARTHRITIS PHASE 2B STUDY

Authors

P. Nash, Griffith University
M. E. Luggen, University of Cincinnati
L. Espinoza, LSU Health Sciences Center - New Orleans
F. J. García Fructuoso, Hospital CIMA Sanitas
R. C. Chou, University at Buffalo
A. M. Mendelsohn, Sun Pharmaceutical Industries, Inc
S. Rozzo, Sun Pharmaceutical Industries, Inc
I. Mcinnes, University of Glasgow

Document Type

Article

Publication Date

6-2-2020

Publication Title

Annals of the Rheumatic Diseases

Volume

79(Suppl 1)

Comments

Abstract Number: SAT0431

Recommended Citation

Nash, P.; Luggen, M. E.; Espinoza, L.; García Fructuoso, F. J.; Chou, R. C.; Mendelsohn, A. M.; Rozzo, S.; and Mcinnes, I., "PROPORTIONS OF PATIENTS ACHIEVING A MINIMAL DISEASE ACTIVITY STATE UPON TREATMENT WITH TILDRAKIZUMAB IN A PSORIATIC ARTHRITIS PHASE 2B STUDY" (2020). School of Medicine Faculty Publications. 1761.
https://digitalscholar.lsuhsc.edu/som_facpubs/1761
10.1136/annrheumdis-2020-eular.3947